MAGENTIQ EYE just raised a major Series A round led by healthtech powerhouse aMoon, signaling a bold bet on the future of AI-powered gastroenterology. Its flagship software, MAGENTIQ-COLO™, already FDA- and CE-approved, is being hailed as one of the most accurate AI tools for polyp detection during colonoscopies.
But that’s just the beginning. With new features like real-time AI reports, polyp type prediction, and tools for diseases like ulcerative colitis and Barrett’s esophagus, the company isn’t just improving diagnostics—it’s redefining the gold standard for GI care.
Backed by top European and American investors, and expanding rapidly across the U.S. and Europe, MAGENTIQ EYE may soon be the AI co-pilot every gastroenterologist needs.